Showing results (101-110 of 324) with videos related to
Sort By:
Pageof 33
Globalization and Health|September 28, 2024
Assessing the health status of migrants upon arrival in Europe: a systematic review of the adverse impact of migration journeysCristina Canova, Lucia Dansero, Cinzia Destefanis, et al.Gastroenterology|December 4, 2004
Colorectal cancer vaccines: principles, results, and perspectivesSimone Mocellin, Carlo Riccardo Rossi, Mario Lise, et al.Trends in Molecular Medicine|February 21, 2006
Circulating tumor cells: the 'leukemic phase' of solid cancersSimone Mocellin, Ulrich Keilholz, Carlo Riccardo Rossi, et al.Surgery|June 21, 2011
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 casesSimone Mocellin, Sandro Pasquali, Carlo Riccardo Rossi, et al.Journal of Translational Medicine|April 24, 2004
Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomyMarco Grasso, Caterina Lania, Salvatore Blanco, et al.Surgical Oncology Clinics of North America|May 20, 2008
Recent advances in conventional and molecular prognostic factors for gastric carcinomaDonato Nitti, Simone Mocellin, Alberto Marchet, et al.In Vivo (Athens, Greece)|November 16, 2014
Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classificationMarco Rastrelli, Saveria Tropea, Carlo Riccardo Rossi, et al.The Lancet. Oncology|November 4, 2004
Part I: Vaccines for solid tumoursSimone Mocellin, Susanna Mandruzzato, Vincenzo Bronte, et al.Cancer Immunology, Immunotherapy : CII|November 20, 2002
Adjuvant immunotherapy for solid tumors: from promise to clinical applicationSimone Mocellin, Carlo R Rossi, Mario Lise, et al.Cancer Treatment Reviews|February 13, 2017
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysisSandro Pasquali, Vanna Chiarion-Sileni, Carlo Riccardo Rossi, et al.Pageof 33